Name: Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142
Price: 42.80 EUR
Availability: InStock
Author: And Quality, Agency for Healthcare Resea ; Human Services, U. S. Department of Heal
ISBN: 9781500350529

portada Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142

Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142

Type

Physical Book

Author

U. S. Department of Heal Human Services

Agency for Healthcare Resea And Quality

Publisher

Createspace

Language

English

Pages

442

Format

Paperback

Dimensions

28.0 x 21.6 x 2.3 cm

Weight

1.02 kg.

ISBN13

9781500350529

Synopsis "Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142"

B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are promising markers for heart failure diagnosis, prognosis, and treatment. This systematic review addresses these four main questions: 1. What are the determinants of both BNP and NT-proBNP measurement? 2. With respect to the diagnosis of heart failure: a. What are the clinical performance characteristics of both BNP and NT-proBNP measurement in patients with symptoms suggestive of heart failure (HF) or with known HF i. presenting to the emergency department (ED) ii. in a specialized clinic or outpatient setting iii. presenting to a primary care setting iv. presenting in long term care setting v. all settings combined b. Does measurement of BNP or NT-proBNP add independent diagnostic information to the traditional diagnostic measures of HF in patients with symptoms suggestive of HF? 3. Do BNP or NT-proBNP levels predict cardiac events in populations: a. Specific populations i. at risk for coronary artery disease (CAD) ii. with diagnosed CAD iii. with diagnosed HF b. What are the screening characteristics of BNP or NT-proBNP in general asymptomatic populations? 4. Can BNP or NT-proBNP measurement be used to monitor response to therapy?

Customers reviews

Have you read this book? Login to add your review.

More customer reviews

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews

Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142 - And Quality, Agency for Healthcare Resea ; Human Services, U. S. Department of Heal

Synopsis "Testing for BNP and NT-proBNP in the Diagnosis and Prognosis of Heart Failure: Evidence Report/Technology Assessment Number 142"

Customers reviews

Frequently Asked Questions about the Book

Is the book original?

In what language is the book written?

What is the format of this book?

Questions and Answers about the Book

Opinions about Bookdelivery